Interestingly, Arabkheradmand et al (11) reported an association between miR-124 down-regulation and advanced clinical stage and the presence of lymph node metastasis in Iranian patients with breast cancer, however, they found no association between microRNA expression and HER2 status. Here, ERBB2 is linked to breast carcinoma.